Glukosetoleranz und Diabetes mellitus im Alter
Publisher
Springer Vienna
Reference156 articles.
1. Abbasi F, Carantonie M, Kamath V, Chen Y-DI, Rizvi AA, Reaven GM (1997) Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylureatreated patients. Diabetes Care 20: 1863–1869
2. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46: 1473–1480
3. Akasaka T, Yoshida K, Hozumi T, Takagie G, Kaji S, Kawamoto T, Morioka S, Yoshikawa J (1997) Retinopathy identifies marked restriction of coronary blood flow reserve in patients with diabetes mellitus. J Am Coll Cardiol 30: 935–941
4. Alberti KG, Johnson AB, Taylor R (1992) Gliclazide: metabolic and vascular effects — a perspective. Metabolism 41: 40–45
5. Antonucci T, McLain R, Whitcomb R, Lockwood D (1997) Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglizazone. Diabetes Care 20: 188–193